narciclasine has been researched along with Esophageal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, N; Fang, B; Li, A; Qiu, Y; Thuy, NTT; Yoo, HM; Zheng, X | 1 |
1 other study(ies) available for narciclasine and Esophageal Neoplasms
| Article | Year |
|---|---|
Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway.
Topics: Amaryllidaceae Alkaloids; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Esophageal Neoplasms; Humans; Phenanthridines; Signal Transduction | 2022 |